48 related articles for article (PubMed ID: 12576438)
1. Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors.
Souid AK; Dubowy RL; Blaney SM; Hershon L; Sullivan J; McLeod WD; Bernstein ML
Clin Cancer Res; 2003 Feb; 9(2):703-10. PubMed ID: 12576438
[TBL] [Abstract][Full Text] [Related]
2. Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium.
Trippett TM; Herzog C; Whitlock JA; Wolff J; Kuttesch J; Bagatell R; Hunger SP; Boklan J; Smith AA; Arceci RJ; Katzenstein HM; Harbison C; Zhou X; Lu H; Langer C; Weber M; Gore L
J Clin Oncol; 2009 Oct; 27(30):5102-8. PubMed ID: 19770383
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.
Wagner LM; Perentesis JP; Reid JM; Ames MM; Safgren SL; Nelson MD; Ingle AM; Blaney SM; Adamson PC
Pediatr Blood Cancer; 2010 Apr; 54(4):538-45. PubMed ID: 20049936
[TBL] [Abstract][Full Text] [Related]
4. NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.
Cecchini M; Walther Z; Wei W; Hafez N; Pilat MJ; Boerner SA; Durecki DE; Eder JP; Schalper KA; Chen AP; LoRusso P
Cancer Res Commun; 2023 Jun; 3(6):1113-1117. PubMed ID: 37377610
[TBL] [Abstract][Full Text] [Related]
5. Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial.
Wu MF; Cheng XY; Wang DY; Lai YT; Li H; Ye YF; Peng YP; Chen Q; Zhang BZ; Lin ZQ; Li J
Gynecol Oncol; 2024 Feb; 181():125-132. PubMed ID: 38159362
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.
McKibbin T; Panetta JC; Fouladi M; Gajjar A; Bai F; Okcu MF; Stewart CF
Clin Cancer Res; 2010 Feb; 16(3):1049-57. PubMed ID: 20103669
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of cisplatin and its monohydrated complex in humans.
Andersson A; Fagerberg J; Lewensohn R; Ehrsson H
J Pharm Sci; 1996 Aug; 85(8):824-7. PubMed ID: 8863271
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of cisplatin in combined cisplatin and 5-fluorouracil therapy: a comparative study of three different schedules of cisplatin administration.
Ikeda K; Terashima M; Kawamura H; Takiyama I; Koeda K; Takagane A; Sato N; Ishida K; Iwaya T; Maesawa C; Yoshinari H; Saito K
Jpn J Clin Oncol; 1998 Mar; 28(3):168-75. PubMed ID: 9614438
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma.
Chavez-Dominguez R; Aguilar-Cazares D; Perez-Medina M; Avila-Rios S; Soto-Nava M; Mendez-Tenorio A; Islas-Vazquez L; Benito-Lopez JJ; Galicia-Velasco M; Lopez-Gonzalez JS
Front Oncol; 2023; 13():1208403. PubMed ID: 37916165
[TBL] [Abstract][Full Text] [Related]
10. Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report.
Li M; Chen W; Sun X; Wang Z; Zou X; Wei H; Wang Z; Chen W
BMC Med Genet; 2019 Sep; 20(1):157. PubMed ID: 31510946
[TBL] [Abstract][Full Text] [Related]
11. Identification of FDA-Approved Drugs with Activity against Stationary Phase
Li T; Feng J; Xiao S; Shi W; Sullivan D; Zhang Y
Antibiotics (Basel); 2019 Apr; 8(2):. PubMed ID: 31035691
[No Abstract] [Full Text] [Related]
12. Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial.
Chang H; Yi W; Wang X; Tao Y; Yang X; Chen C; Zhang W; Zhou S; Liu S; Li X; Ding S; Li J; Li G; Shao X; Liu Y; Song W; Xia Y
Chin J Cancer Res; 2018 Jun; 30(3):307-314. PubMed ID: 30046225
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.
Bautista F; Fioravantti V; de Rojas T; Carceller F; Madero L; Lassaletta A; Moreno L
Cancer Med; 2017 Nov; 6(11):2606-2624. PubMed ID: 28980418
[TBL] [Abstract][Full Text] [Related]
14. Treatment of childhood astrocytomas with irinotecan and cisplatin.
Mora J; Perez-Jaume S; Cruz O
Clin Transl Oncol; 2018 Apr; 20(4):500-507. PubMed ID: 28828715
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of platinum compounds on renal cellular respiration in mice.
Almarzooqi SS; Alfazari AS; Abdul-Kader HM; Saraswathiamma D; Albawardi AS; Souid AK
Int J Clin Exp Pathol; 2015; 8(1):81-95. PubMed ID: 25755695
[TBL] [Abstract][Full Text] [Related]
16. In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma.
Veringa SJ; Biesmans D; van Vuurden DG; Jansen MH; Wedekind LE; Horsman I; Wesseling P; Vandertop WP; Noske DP; Kaspers GJ; Hulleman E
PLoS One; 2013; 8(4):e61512. PubMed ID: 23637844
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
Swami U; Goel S; Mani S
Curr Drug Targets; 2013 Jun; 14(7):777-97. PubMed ID: 23597015
[TBL] [Abstract][Full Text] [Related]
18. Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines.
Pasini A; Paganelli G; Tesei A; Zoli W; Giordano E; Calistri D
Transl Oncol; 2012 Dec; 5(6):461-8. PubMed ID: 23397475
[TBL] [Abstract][Full Text] [Related]
19. Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?
Bellanti F; Kågedal B; Della Pasqua O
Eur J Clin Pharmacol; 2011 May; 67 Suppl 1(Suppl 1):87-107. PubMed ID: 21287160
[TBL] [Abstract][Full Text] [Related]
20. Use of amifostine in the treatment of recurrent solid tumours in children.
Sidi V; Arsos G; Papakonstantinou E; Hatzipantelis E; Fragandrea I; Gombakis N; Koliouskas E
Hippokratia; 2007 Jan; 11(1):25-9. PubMed ID: 19582173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
